Shepherd Street Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.85M Buy
1,601
+15
+0.9% +$15.3K 1.63% 19
2026
Q1
$1.46M Buy
1,586
+50
+3% +$50.7K 1.44% 24
2025
Q4
$1.65M Buy
+1,536
New +$1.47M 1.58% 21

Other funds holding LLY

Shepherd Street Advisors's LLY Position: Q2 2026 in Review

Shepherd Street Advisors increased its Eli Lilly (LLY) stake by 0.95% in Q2 2026, buying an estimated $15.3K and bringing the position to 1,601 shares worth $1.85M. The position accounts for 1.63% of the portfolio, ranked #19.

Shepherd Street Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Shepherd Street Advisors held 1,601 shares of Eli Lilly worth $1.85M as of Q2 2026.
  • Shepherd Street Advisors bought 15 Eli Lilly shares in Q2 2026, an estimated $15.3K.
  • Eli Lilly made up 1.63% of Shepherd Street Advisors's portfolio in Q2 2026, its #19 holding.
  • Shepherd Street Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Shepherd Street Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.